Capital Advisors Ltd’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $645K | Buy |
4,442
+97
| +2% | +$13.4K | 0.07% | 156 |
|
|
2026
Q2 | $558K | Sell |
4,345
-45
| -1% | -$5.27K | 0.06% | 175 |
|
|
2026
Q1 | $528K | Sell |
4,390
-96
| -2% | -$11.1K | 0.06% | 167 |
|
|
2025
Q4 | $472K | Sell |
4,486
-101
| -2% | -$9.48K | 0.05% | 182 |
|
|
2025
Q3 | $385K | Sell |
4,587
-145
| -3% | -$11.9K | 0.04% | 200 |
|
|
2025
Q2 | $375K | Buy |
4,732
+66
| +1% | +$5.25K | 0.05% | 195 |
|
|
2025
Q1 | $419K | Sell |
4,666
-388
| -8% | -$36.2K | 0.06% | 175 |
|
|
2024
Q4 | $503K | Buy |
5,054
+310
| +7% | +$32K | 0.06% | 157 |
|
|
2024
Q3 | $539K | Sell |
4,744
-208
| -4% | -$24.7K | 0.07% | 151 |
|
|
2024
Q2 | $613K | Buy |
4,952
+263
| +6% | +$33.9K | 0.08% | 137 |
|
|
2024
Q1 | $619K | Buy |
4,689
+146
| +3% | +$18K | 0.08% | 136 |
|
|
2023
Q4 | $495K | Sell |
4,543
-29
| -0.6% | -$3.01K | 0.07% | 155 |
|
|
2023
Q3 | $471K | Sell |
4,572
-41
| -0.9% | -$4.42K | 0.07% | 151 |
|
|
2023
Q2 | $532K | Buy |
4,613
+2,083
| +82% | +$237K | 0.08% | 144 |
|
|
2023
Q1 | $269K | Sell |
2,530
-1,422
| -36% | -$154K | 0.04% | 197 |
|
|
2022
Q4 | $284K | Buy |
3,952
+1,685
| +74% | +$172K | 0.05% | 187 |
|
|
2022
Q3 | $195K | Sell |
2,267
-68
| -3% | -$6.07K | 0.04% | 234 |
|
|
2022
Q2 | $213K | Sell |
2,335
-101
| -4% | -$8.95K | 0.04% | 218 |
|
|
2022
Q1 | $200K | Buy |
2,436
+139
| +6% | +$11K | 0.03% | 230 |
|
|
2021
Q4 | $176K | Buy |
2,297
+245
| +12% | +$19.5K | 0.03% | 240 |
|
|
2021
Q3 | $154K | Hold |
2,052
| – | – | 0.03% | 242 |
|
|
2021
Q2 | $160K | Hold |
2,052
| – | – | 0.03% | 226 |
|
|
2021
Q1 | $158K | Hold |
2,052
| – | – | 0.03% | 203 |
|
|
2020
Q4 | $168K | Hold |
2,052
| – | – | 0.04% | 191 |
|
|
2020
Q3 | $170K | Hold |
2,052
| – | – | 0.04% | 175 |
|
|
2020
Q2 | $159K | Sell |
2,052
-526
| -20% | -$41.5K | 0.04% | 175 |
|
|
2020
Q1 | $198K | Buy |
2,578
+129
| +5% | +$10.6K | 0.06% | 147 |
|
|
2019
Q4 | $223K | Buy |
2,449
+120
| +5% | +$10.3K | 0.06% | 146 |
|
|
2019
Q3 | $196K | Hold |
2,329
| – | – | 0.05% | 146 |
|
|
2019
Q2 | $195K | Buy |
2,329
+200
| +9% | +$16K | 0.06% | 146 |
|
|
2019
Q1 | $177K | Hold |
2,129
| – | – | 0.05% | 160 |
|
|
2018
Q4 | $163K | Hold |
2,129
| – | – | 0.05% | 160 |
|
|
2018
Q3 | $151K | Hold |
2,129
| – | – | 0.04% | 173 |
|
|
2018
Q2 | $129K | Hold |
2,129
| – | – | 0.04% | 157 |
|
|
2018
Q1 | $116K | Hold |
2,129
| – | – | 0.04% | 165 |
|
|
2017
Q4 | $120K | Hold |
2,129
| – | – | 0.04% | 160 |
|
|
2017
Q3 | $136K | Hold |
2,129
| – | – | 0.05% | 146 |
|
|
2017
Q2 | $136K | Hold |
2,129
| – | – | 0.05% | 146 |
|
|
2017
Q1 | $135K | Hold |
2,129
| – | – | 0.05% | 140 |
|
|
2016
Q4 | $125K | Hold |
2,129
| – | – | 0.05% | 138 |
|
|
2016
Q3 | $133K | Hold |
2,129
| – | – | 0.06% | 132 |
|
|
2016
Q2 | $123K | Hold |
2,129
| – | – | 0.06% | 135 |
|
|
2016
Q1 | $113K | Hold |
2,129
| – | – | 0.06% | 134 |
|
|
2015
Q4 | $112K | Hold |
2,129
| – | – | 0.06% | 131 |
|
|
2015
Q3 | $105K | Hold |
2,129
| – | – | 0.06% | 129 |
|
|
2015
Q2 | $121K | Buy |
2,129
+146
| +7% | +$8.58K | 0.06% | 124 |
|
|
2015
Q1 | $114K | Buy |
1,983
+50
| +3% | +$2.97K | 0.06% | 129 |
|
|
2014
Q4 | $110K | Hold |
1,933
| – | – | 0.06% | 120 |
|
|
2014
Q3 | $114K | Hold |
1,933
| – | – | 0.06% | 124 |
|
|
2014
Q2 | $112K | Hold |
1,933
| – | – | 0.06% | 129 |
|
|
2014
Q1 | $110K | Hold |
1,933
| – | – | 0.06% | 132 |
|
|
2013
Q4 | $97K | Hold |
1,933
| – | – | 0.06% | 112 |
|
Other funds holding MRK
Capital Advisors Ltd's MRK Position: Q3 2026 in Review
Capital Advisors Ltd increased its Merck (MRK) stake by 2.2% in Q3 2026, buying an estimated $13.4K and bringing the position to 4,442 shares worth $645K. The position accounts for 0.07% of the portfolio, ranked #156.
Capital Advisors Ltd first reported a position in MRK in Q4 2013 and has held it in 52 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Capital Advisors Ltd held 4,442 shares of Merck worth $645K as of Q3 2026.
- Capital Advisors Ltd bought 97 Merck shares in Q3 2026, an estimated $13.4K.
- Merck made up 0.07% of Capital Advisors Ltd's portfolio in Q3 2026, its #156 holding.
- Capital Advisors Ltd first reported a position in Merck in Q4 2013 and has held it in 52 quarters since.
- 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.